BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 29706455)

  • 1. Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells.
    Ahn J; Xia T; Rabasa Capote A; Betancourt D; Barber GN
    Cancer Cell; 2018 May; 33(5):862-873.e5. PubMed ID: 29706455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity.
    McAndrews KM; Che SPY; LeBleu VS; Kalluri R
    J Biol Chem; 2021; 296():100523. PubMed ID: 33711340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors.
    Francica BJ; Ghasemzadeh A; Desbien AL; Theodros D; Sivick KE; Reiner GL; Hix Glickman L; Marciscano AE; Sharabi AB; Leong ML; McWhirter SM; Dubensky TW; Pardoll DM; Drake CG
    Cancer Immunol Res; 2018 Apr; 6(4):422-433. PubMed ID: 29472271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous non-coding dsDNA-dependent trans-activation of phagocytes augments anti-tumor immunity.
    Delaunay T; Son S; Park S; Kaur B; Ahn J; Barber GN
    Cell Rep Med; 2024 May; 5(5):101528. PubMed ID: 38677283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
    Woo SR; Fuertes MB; Corrales L; Spranger S; Furdyna MJ; Leung MY; Duggan R; Wang Y; Barber GN; Fitzgerald KA; Alegre ML; Gajewski TF
    Immunity; 2014 Nov; 41(5):830-42. PubMed ID: 25517615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Cyclic Dinucleotides by STING.
    Du XX; Su XD
    Methods Mol Biol; 2017; 1657():59-69. PubMed ID: 28889286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of Phagocytosis Checkpoint Silencer and Stimulator of Interferon Genes Agonist for Synergetic Cancer Immunotherapy.
    Lu ZD; Chen YF; Shen S; Xu CF; Wang J
    ACS Appl Mater Interfaces; 2021 Jun; 13(25):29424-29438. PubMed ID: 34129318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
    Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of IACS-8803 and IACS-8779, potent agonists of stimulator of interferon genes (STING) with robust systemic antitumor efficacy.
    Ager CR; Zhang H; Wei Z; Jones P; Curran MA; Di Francesco ME
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126640. PubMed ID: 31500996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses.
    Walker MM; Crute BW; Cambier JC; Getahun A
    J Immunol; 2018 Nov; 201(9):2641-2653. PubMed ID: 30282750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential.
    Dejmek M; Šála M; Brazdova A; Vanekova L; Smola M; Klíma M; Břehová P; Buděšínský M; Dračínský M; Procházková E; Zavřel M; Šimák O; Páv O; Boura E; Birkuš G; Nencka R
    Structure; 2022 Aug; 30(8):1146-1156.e11. PubMed ID: 35690061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Biological Evaluation of (2',5' and 3'5'-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING).
    Xie X; Liu J; Wang X
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33198423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis.
    Xia T; Konno H; Barber GN
    Cancer Res; 2016 Nov; 76(22):6747-6759. PubMed ID: 27680683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy.
    Wilson DR; Sen R; Sunshine JC; Pardoll DM; Green JJ; Kim YJ
    Nanomedicine; 2018 Feb; 14(2):237-246. PubMed ID: 29127039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCV2 infection activates the cGAS/STING signaling pathway to promote IFN-β production and viral replication in PK-15 cells.
    Huang B; Zhang L; Lu M; Li J; Lv Y
    Vet Microbiol; 2018 Dec; 227():34-40. PubMed ID: 30473349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Loss of Responsiveness to Exogenous but Not Endogenous Cyclic-Dinucleotides in Mice Expressing STING-R231H.
    Walker MM; Kim S; Crisler WJ; Nguyen K; Lenz LL; Cambier JC; Getahun A
    Front Immunol; 2020; 11():238. PubMed ID: 32153571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
    Deng L; Liang H; Xu M; Yang X; Burnette B; Arina A; Li XD; Mauceri H; Beckett M; Darga T; Huang X; Gajewski TF; Chen ZJ; Fu YX; Weichselbaum RR
    Immunity; 2014 Nov; 41(5):843-52. PubMed ID: 25517616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.
    Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH
    J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
    Anghelina D; Lam E; Falck-Pedersen E
    J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.
    Vyskocil S; Cardin D; Ciavarri J; Conlon J; Cullis C; England D; Gershman R; Gigstad K; Gipson K; Gould A; Greenspan P; Griffin R; Gulavita N; Harrison S; Hu Z; Hu Y; Hata A; Huang J; Huang SC; Janowick D; Jones M; Kolev V; Langston SP; Lee HM; Li G; Lok D; Ma L; Mai D; Malley J; Matsuda A; Mizutani H; Mizutani M; Molchanova N; Nunes E; Pusalkar S; Renou C; Rowland S; Sato Y; Shaw M; Shen L; Shi Z; Skene R; Soucy F; Stroud S; Xu H; Xu T; Abu-Yousif AO; Zhang J
    J Med Chem; 2021 May; 64(10):6902-6923. PubMed ID: 34000802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.